RSS

psoriatic arthritis (PsA)

The US Food and Drug Administration (FDA) has approved Novartis’ Cosentyx (secukinumab) for the treatment of adult patients with active ankylosing spondylitis (AS) and active psoriatic arthritis (PsA) more

News